IL-1β knockout increases the intestinal abundancy of Akkermansia muciniphila.
Maren BechbergerTatjana EigenbrodSebastien BoutinK HeegK A BodePublished in: Beneficial microbes (2023)
The proinflammatory cytokine interleukin-1β (IL-1β) is known to be upregulated in patients suffering from metabolic syndrome. IL-1β contributes to insulin resistance in obesity and type 2 diabetes, yet its influence on the intestinal microbiome is incompletely understood. The data presented here demonstrate that mice genetically deficient in IL-1β show a specific alteration of intestinal colonisation of a small group of bacteria. Especially Akkermansia muciniphila, a bacterium reported to be inversely associated with obesity, diabetes, cardiometabolic diseases and low-grade inflammation, showed increased colonisation in IL-1β knockout mice. In comparative microarray analysis from mucus scrapings of the colon mucosa of IL-1β knockout and wildtype mice, angiogenin 4 mRNA was strongly reduced in IL-1β knockout animals. Since the presence of angiogenin 4 in the culture medium showed a significant growth inhibition on A. muciniphila which was not detectable for other bacteria tested, IL-1β induced expression of angiogenin 4 is a strong candidate to be responsible for the IL-1β induced suppression of A. muciniphila colonisation. Thus, the data presented here indicate that IL-1β might be the lacking link between inflammation and suppression of A. muciniphila abundance as observed in a variety of chronic inflammatory disorders.
Keyphrases
- type diabetes
- metabolic syndrome
- low grade
- oxidative stress
- insulin resistance
- cardiovascular disease
- high fat diet induced
- high grade
- newly diagnosed
- physical activity
- ejection fraction
- skeletal muscle
- machine learning
- body mass index
- chronic kidney disease
- electronic health record
- glycemic control
- artificial intelligence
- adipose tissue
- wild type
- patient reported